Profile data is unavailable for this security.
About the company
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
- Revenue in USD (TTM)705.71m
- Net income in USD6.01m
- Incorporated2007
- Employees1.01k
- LocationInspire Medical Systems Inc5500 Wayzata Blvd Ste 1600GOLDEN VALLEY 55416-1237United StatesUSA
- Phone+1 (763) 957-5037
- Fax+1 (302) 655-5049
- Websitehttps://www.inspiresleep.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neogen Corp | 924.22m | -9.42m | 3.78bn | 2.92k | -- | 1.20 | 35.26 | 4.09 | -0.0435 | -0.0435 | 4.27 | 14.51 | 0.203 | 2.85 | 5.67 | 316,839.90 | -0.207 | 1.38 | -0.214 | 1.44 | 50.19 | 48.23 | -1.02 | 4.31 | 2.59 | 1.19 | 0.2208 | 0.00 | 12.37 | 17.41 | 58.81 | -- | 50.02 | -- |
Haemonetics Corporation | 1.33bn | 114.89m | 3.83bn | 3.66k | 33.52 | 4.23 | 17.55 | 2.87 | 2.23 | 2.23 | 25.92 | 17.70 | 0.5924 | 1.87 | 7.05 | 364,751.20 | 5.10 | 5.02 | 5.74 | 6.07 | 53.58 | 51.74 | 8.61 | 8.11 | 2.33 | 60.20 | 0.5747 | 0.00 | 12.01 | 6.23 | 1.87 | 16.40 | -11.04 | -- |
ICU Medical Inc | 2.30bn | -70.79m | 4.32bn | 14.00k | -- | 2.12 | 27.53 | 1.87 | -2.92 | -2.92 | 94.90 | 83.43 | 0.5267 | 2.13 | 14.68 | 164,591.20 | -1.62 | 1.46 | -1.83 | 1.65 | 32.47 | 34.11 | -3.07 | 2.23 | 1.08 | 0.5555 | 0.4412 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
Integer Holdings Corp | 1.67bn | 105.37m | 4.34bn | 10.50k | 42.43 | 2.79 | 20.74 | 2.60 | 3.05 | 3.05 | 48.27 | 46.34 | 0.5574 | 4.88 | 5.10 | 158,938.20 | 3.52 | 3.28 | 3.78 | 3.53 | 26.77 | 26.94 | 6.31 | 6.40 | 1.96 | 3.67 | 0.4215 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
Procept Biorobotics Corp | 176.58m | -103.71m | 4.37bn | 626.00 | -- | 17.52 | -- | 24.75 | -2.06 | -2.06 | 3.50 | 4.85 | 0.546 | 1.85 | 3.83 | 282,068.70 | -32.07 | -- | -36.52 | -- | 54.73 | -- | -58.73 | -- | 6.49 | -- | 0.1696 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
DENTSPLY SIRONA Inc | 3.90bn | -185.00m | 5.33bn | 15.00k | -- | 1.74 | 32.50 | 1.37 | -0.8698 | -0.8698 | 18.65 | 15.12 | 0.5356 | 2.94 | 6.18 | 259,733.30 | -2.49 | -1.14 | -3.03 | -1.32 | 52.23 | 53.65 | -4.65 | -2.51 | 0.8692 | 3.65 | 0.4066 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
TransMedics Group Inc | 358.76m | 3.00m | 5.50bn | 584.00 | 3,999.03 | 28.95 | 316.38 | 15.34 | 0.0413 | 0.0413 | 10.61 | 5.70 | 0.4952 | 3.56 | 5.58 | 614,313.40 | 0.4141 | -16.08 | 0.4403 | -17.95 | 60.71 | 65.37 | 0.8362 | -40.47 | 8.48 | -- | 0.7278 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
Merit Medical Systems Inc | 1.30bn | 117.43m | 5.80bn | 6.95k | 49.63 | 4.52 | 27.23 | 4.45 | 2.01 | 2.01 | 22.24 | 22.04 | 0.6183 | 2.30 | 7.36 | 187,231.10 | 5.58 | 2.45 | 6.13 | 2.77 | 46.54 | 44.50 | 9.02 | 3.91 | 4.64 | 17.52 | 0.3846 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
Stevanato Group SpA | 1.21bn | 136.81m | 5.83bn | 5.64k | 37.50 | 3.56 | 25.73 | 4.80 | 0.5136 | 0.5136 | 4.54 | 5.42 | 0.543 | 2.66 | 2.80 | 215,440.70 | 6.12 | -- | 8.34 | -- | 30.06 | -- | 11.27 | -- | 1.13 | 44.77 | 0.1926 | -- | 10.34 | -- | 1.95 | -- | -- | -- |
Inspire Medical Systems Inc | 705.71m | 6.01m | 6.35bn | 1.01k | 1,099.89 | 9.94 | 644.81 | 8.99 | 0.1935 | 0.1935 | 23.74 | 21.41 | 1.05 | 2.68 | 9.86 | 698,026.70 | 0.8927 | -11.27 | 0.99 | -12.60 | 84.83 | 84.47 | 0.8518 | -13.57 | 8.35 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
Masimo Corp | 2.02bn | 79.40m | 6.49bn | 3.80k | 82.59 | 4.72 | 37.18 | 3.22 | 1.47 | 1.47 | 37.32 | 25.73 | 0.6831 | 1.94 | 5.77 | 530,763.20 | 2.69 | 8.65 | 3.32 | 10.31 | 49.28 | 57.30 | 3.94 | 12.03 | 1.15 | 3.30 | 0.3635 | 0.00 | 0.6042 | 19.00 | -43.21 | -15.96 | 31.06 | -- |
Glaukos Corp | 341.73m | -158.61m | 7.02bn | 907.00 | -- | 10.53 | -- | 20.55 | -3.20 | -3.20 | 6.91 | 12.13 | 0.3642 | 1.67 | 7.55 | 376,764.10 | -16.91 | -8.73 | -18.20 | -9.35 | 76.53 | 74.77 | -46.41 | -28.69 | 4.67 | -56.93 | 0.16 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
Penumbra Inc | 1.13bn | 14.23m | 7.57bn | 4.20k | 571.01 | 6.52 | 174.64 | 6.68 | 0.3415 | 0.3415 | 28.94 | 29.90 | 0.7642 | 1.07 | 5.53 | 269,924.50 | 0.9595 | 2.32 | 1.07 | 2.61 | 65.45 | 63.90 | 1.26 | 3.17 | 3.77 | -- | 0.0209 | 0.00 | 24.95 | 18.93 | 4,643.16 | 68.60 | 9.64 | -- |
Lantheus Holdings Inc | 1.44bn | 428.48m | 7.64bn | 834.00 | 18.02 | 7.44 | 15.64 | 5.31 | 6.11 | 6.11 | 20.48 | 14.79 | 0.8775 | 8.35 | 4.58 | 1,724,234.00 | 26.15 | 6.69 | 29.96 | 7.73 | 64.49 | 57.56 | 29.80 | 9.02 | 4.41 | -- | 0.3546 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
Repligen Corp | 602.35m | -1.90m | 8.01bn | 1.78k | -- | 4.02 | 116.73 | 13.29 | -0.0416 | -0.0416 | 10.67 | 35.53 | 0.2226 | 1.46 | 4.95 | 337,831.80 | -0.0703 | 4.38 | -0.0782 | 5.03 | 47.70 | 55.43 | -0.3156 | 15.91 | 5.56 | -- | 0.2282 | 0.00 | -20.31 | 26.91 | -77.64 | 20.13 | 24.99 | -- |
Holder | Shares | % Held |
---|---|---|
Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 3.86m | 12.98% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 2.85m | 9.59% |
Wellington Management Co. LLPas of 31 Mar 2024 | 1.87m | 6.29% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 1.46m | 4.93% |
Baillie Gifford & Co.as of 30 Jun 2024 | 1.43m | 4.80% |
Wasatch Advisors LPas of 31 Mar 2024 | 1.10m | 3.71% |
William Blair Investment Management LLCas of 30 Jun 2024 | 777.33k | 2.62% |
Frontier Capital Management Co. LLCas of 31 Mar 2024 | 684.74k | 2.31% |
Newton Investment Management North America LLCas of 30 Jun 2024 | 660.73k | 2.22% |
Champlain Investment Partners LLCas of 31 Mar 2024 | 641.69k | 2.16% |